BioSpace News Archive

Modular Devices Acquisition, LLC (Modular Devices), a leading provider of mobile cath labs and mobile cleanrooms, today announced the acquisition of Cardiac Services Mobile, Inc. (Cardiac Services Mobile), a mobile cath lab company out of Nashville, TN that serves the US markets.

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that its 2022 Annual and Special Meeting (“the Meeting”) is scheduled for Wednesday, June 8, 2022 at 4:00 p.m.

Mersana Therapeutics, Inc. announced that on May 2, 2022, an authorized sub-committee of the Compensation Committee of the Board of Directors of Mersana granted inducement awards, consisting of stock options to purchase an aggregate of 152,100 shares of its common stock and restricted stock unit awards to acquire an aggregate of 10,050 shares of its common stock, to seven new employees whose employment commenced in April 2022.

At the International Society for Magnetic Resonance in Medicine 2022 Annual Meeting, GE Healthcare boasts the continued expansion of its pioneering deep learning image reconstruction solution, AIR Recon DL, to its tens of thousands of install base customers as an upgrade as well as with new purchases across its MR product portfolio.

Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the Company will present at the following upcoming investor conferences.

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

Bausch Health Companies Inc. announced its full leadership team and Board of Directors, including Chief Executive Officer Thomas J. Appio.1 Upon completion of the initial public offering of the Bausch + Lomb eye health business,2 former CEO Joseph C. Papa will assume the role of chairman and CEO of Bausch + Lomb.

Bausch + Lomb Corporation launched as a publicly traded company focused on protecting and enhancing the gift of sight for millions of people around the world when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.

The Board of Directors of Eli Lilly and Company has elected Mary Lynne Hedley, Ph.D., as a new member, effective May 15, 2022.

Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the first quarter ended March 31, 2022.